IDH1 and central nervous system cancer: Meanwhile, IDH1- and TP53-mutant gliomas possessing more differentiated GSC subpopulations, diversified on oligodendrocyte- and astroglia-like phenotypes, that could be targeted by their common property of migration/invasion, using adhesion molecules, such as CD44.